NCT07187297View on ClinicalTrials.gov

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

NANot yet recruitingINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

March 31, 2027

Conditions
WrinkleLax SkinLines Skin
Interventions
DEVICE

Thermage FLX

The Thermage FLX System ('System') is a monopolar, capacitively coupled radiofrequency System designed for use in non-invasive dermatological procedures

Trial Locations (1)

10003

Union Square Laser Dermatology, New York

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT07187297 - A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment | Biotech Hunter | Biotech Hunter